Horizon Pharma reported $190.26M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Aerie Pharmaceuticals AERI:US USD 46.76M 245K
Amgen AMGN:US USD 4.76B 203M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Cara Therapeutics CARA:US USD 1.84M 1.62M
Coherus Biosciences CHRS:US USD 27.72M 4.02M
Eli Lilly And LLY:US USD 3.83B 68.3M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Horizon Pharma HZNP:US USD 190.26M 13.42M
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Novartis NOVN:VX USD 6.78B 101M
Pacira Pharmaceuticals PCRX:US USD 96.8M 3.79M
Perrigo Ordinary Shares PRGO:US USD 1.09B 5.6M
Prestige Brands PBH:US USD 140.5M 6.74M
Revance Therapeutics RVNC:US USD 17.18M 3.58M
Supernus Pharmaceuticals SUPN:US USD 83.16M 1.69M
Takeda 4502:JP JPY 953.45B 25.94B
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M
Valeant Pharmaceuticals VRX:CN USD 1.06B 17M
Xeris Pharmaceuticals Inc XERS:US USD 20.12M 2.23M
Zoetis ZTS:US USD 2.3B 98M